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Studies examining the role of the immune system in hypertension and renal disease have largely been dependent upon the use of pharmacological agents (7, 17, 21, 22, 23) , although recent studies have utilized mice in which the immune system has been genetically manipulated to study experimental hypertension (11) . Experiments in our laboratory have examined the influence of two mechanistically dissimilar immunosuppressive agents on the development of salt-induced hypertension and kidney damage in the Dahl salt-sensitive rat (3, 4) , a genetic model of hypertension and renal disease that exhibits many phenotypic characteristics in common with human hypertension (1, 2, 6, 10, 14) . A major concern related to the studies that have used pharmacological agents to suppress the immune system, are the potential nonspecific effects of these agents.
Recently, zinc finger nuclease technology (ZFN) was described as an efficient means to generate targeted mutations in rats (8, 9, 19) . To eliminate the potential side effects of pharmacological agents and to address the role of the immune system in hypertension and renal disease in a genetic model of disease, a ZFN was designed to target recombination-activating gene 1 (Rag1) in the Dahl SS genetic background. Rag1 is a gene product important for somatic recombination in lymphocytes; genetic deletion of Rag1 in mice leads to a depletion of mature T and B lymphocytes (18) . The present studies were performed to develop and validate a ZFN-mediated null mutation of Rag1 in the Dahl SS rat genetic background and to demonstrate the influence of genetic depletion of immune cells in the development of Dahl SS hypertension and kidney disease.
METHODS
All animal procedures and breeding were performed at the Medical College of Wisconsin under protocols approved by the Institutional Animal Care and Use Committee. The generation of ZFN mutants was performed as previously described (8, 9, 19) . ZFN constructs specific for the rat Rag1 gene were designed, assembled, and validated by Sigma-Aldrich (St. Louis, MO), to target bases 672-706 (NCBI reference sequence: NM_053468.1) of Rag1 (target sequence: gtctactgcccaaggaatgtgaccgtggagtggca). In vitro transcribed mRNA encoding the Rag1 ZFNs was diluted in microinjection buffer (1 mmol/l Tris, 0.1 mmol/l EDTA, pH 7.4) at a concentration of 10 ng/l and injected into the pronucleus of 1-cell SS/JrHsdMcwi (SS) rat embryos, as described previously (8) . Two-hundred-and-one embryos were injected and transferred to pseudopregnant Sprague-Dawley females. At 10 days of age, pups were ear punched, and DNA was extracted and screened for ZFN-induced mutations, as described previously. Briefly, DNA extracted from ear tissue was amplified using primers flanking the target sequence (Rag1_F: 5=-CTCATTGCCAGAGTTTTCCG-3= and Rag1_R: 5=-TGCTGACCCTAGCCTGAGTT-3=). PCR products were heat denatured, reannealed (95°C, 2 min; 95°to 85°C, Ϫ2°C/s; 85°to 25°C, Ϫ0.1°C/s; 4°C indefinitely), and subjected to cleavage by the Surveyor Nuclease (Cel-I; Transgenomic, Omaha, NE), according to the manufacturer's instructions. Reaction products were separated on a 10% Tris/borate/EDTA polyacrylamide gel (Bio-Rad Laboratories, Hercules, CA) and poststained with 1ϫ GelStar nucleic acid gel stain (Cambrex Bio Science, Baltimore, MD). Among the pups born, positive mutant founders were identified for further study (Fig. 1) . PCR products from two positive pups were cloned using the pCR2.1-TOPO kit (Invitrogen, Carlsbad, CA), according to the manufacturer's instructions, and 12 individual white colonies were cultured and miniprepped for Sanger sequencing using M13F and M13R primers provided in the kit. Sequencing of the first mutant revealed a 13-base frameshift deletion of bases 681-693 in exon 1 (caaggaatgtgac), resulting in truncation of the normal 1,040-amino acid RAG1 protein after amino acid P186 and insertion of 34 additional nonsense amino acids before a stop codon is introduced. The second mutant has a 17-base frameshift deletion of bases 687-703 (aatgtgaccgtggagtg), resulting in the insertion of a stop codon within 25 bases of the deletion. Previous reports demonstrated that off-target effects of ZFNs are rare and separated from the target locus by backcrossing (9, 16) ; the founder rats were backcrossed to an SS. To minimize possible effects of off-target mutations, multiple separate pairs of mutationcarrying progeny were intercrossed to generate F2 populations that were used for phenotyping and breeding to homozygosity. Fluorescent genotyping was performed in subsequent generations using the same Rag1 primers above, with an M13F sequence tag (5=-TGTAAAAC-GACGGCCAGT-3=) added to the 5= end of the Rag1_F primer, as previously described (20) . Experiments were performed on age-matched, inbred, male Dahl SS rats (SS/JrHSDMcwi), and Dahl SS rats with the 13-base mutation in Rag1 (SS-Rag1 em1Mcwi ). The strain with a 17-base mutation (SS-Rag1 em2Mcwi ) was used in a minimal number of phenotyping experiments to confirm the Rag1-mutant phenotype. The breeders and weanlings were fed purified AIN-76A rodent diet (Dyets, Bethlehem, PA) containing 0.4% NaCl. Within the timeline of these experiments, we noted no differences in survival between the Dahl SS and Rag1-mutant rats.
The experimental methods for phenotyping (isolation of infiltrating mononuclear cells from the kidney, histology, immunohistochemistry, flow cytometry, Western blotting, and surgical preparation of the animals) were all performed using methods previously described (3, 4, 5, 17) .
Immune cell isolation and flow cytometry. Immune cells were isolated from the kidney, spleen, and blood using methods that we previously described (3, 4, 5) . Rats were anesthetized with pentobarbital sodium (50 mg/kg ip); the kidneys were flushed with heparinized saline, minced with a razor blade, and incubated in a PBS solution containing collagenase. Mononuclear cells were separated by centrifugation on Histopaque. In some experiments, infiltrating T cells in the Western blot analysis. Blotting experiments were performed with 100 g of total protein obtained from the thymus in a homogenization solution containing 1% Triton-100. Proteins were separated on an 4 -15% SDS-PAGE gel, transferred to a nitrocellulose membrane (Bio-Rad), blocked for 1 h at room temperature, and incubated overnight with a polyclonal anti-Rag1 primary antibody (Santa Cruz Biotechnology, Santa Cruz, CA) and a monoclonal anti-␤-actin antibody (Sigma) at 4°C. The bound primary antibodies were detected with horseradish peroxidase-labeled secondary antibodies (anti-rabbit IgG, anti-mouse IgG; Thermo Scientific, Waltham, MA) and visualized by chemiluminescence (HyGLO; Denville Scientific, Plainfield, NJ).
Histological and immunohistochemical analysis. Kidneys were obtained for histological and immunohistochemical analysis using methods previously described (3, 4, 5) . Tissue was fixed in 10% formaldehyde, paraffin embedded (Microm HMP 300), cut in 3-m sections (Microm HM355S), mounted, and stained with Gomori's one-step trichrome. For immunohistochemistry, slides were deparaffinized and incubated with proteinase K for antigen retrieval. The primary monoclonal antibody used to detect T cells was anti-CD43 (Abcam). A biotinylated horse anti-mouse secondary antibody was used for development with avidin-biotinylated horseradish peroxidase complex (Vectastain ABC kits; Vector Laboratory, Burlingame, CA). Slides were counterstained with aniline blue dye and photographed.
Surgical preparation. Rats were deeply anesthetized with a mixture of ketamine (75 mg/kg ip), xylazine (10 mg/kg ip), and acepromazine (2.5 mg/kg ip), with supplemental anesthesia administered as needed. Aseptic techniques were used to place polyvinyl catheters in the femoral artery for measurement of arterial pressure. Catheters were tunneled subcutaneously and exteriorized at the back of the neck. In some rats, a telemetry transmitter (Data Sciences International, New Brighton, MN) for measuring arterial blood pressure was aseptically implanted in the carotid artery, with the body of the transmitter implanted subcutaneously in the back of the animal. Animals were maintained on warming trays during and following surgery. Analgesics and antibiotics were administered after surgery to control pain and infection.
Blood pressure and renal disease phenotyping. The influence of an elevated NaCl intake on the development of hypertension and renal damage was assessed in Dahl SS rats and Rag1-mutant rats. At ϳ9 wk of age, the rats were instrumented with telemetry transmitters (Data Sciences International), with the catheter implanted in the carotid artery. The rats were permitted to recover for 3 days; blood pressure was then continuously monitored for 7 days, while the rats were maintained on the 0.4% NaCl chow, and for 21 days following the transition to 4.0% NaCl chow. An overnight urine collection was obtained during the low-salt period and after 7, 14, and 21 days of the high-salt diet. After 3 wk of high-salt intake, the rats were deeply anesthetized, and the kidneys were flushed and prepared for T-cell isolation and counting or for histology and immunohistochemistry. Peripheral blood was obtained from some rats for flow cytometry.
Data are expressed as the means Ϯ SE. Data were assessed for significance using a t-test, a one-way repeated-measures ANOVA with a Tukey post hoc test, or a two-way repeated-measures ANOVA with a Holm-Sidak post hoc test. A probability value of P Ͻ 0.05 was considered significant.
RESULTS
Documentation of Rag1 mutation. As described above, DNA sequencing revealed a 13-base frameshift deletion of bases 681-693 in the SS-Rag1 em1Mcwi mutant rats; aside from a small group of confirmatory studies in SS-Rag1 em2Mcwi , this mutant strain was studied in the present experiments. Validation studies demonstrated a deficit of Rag1 protein in the thymus of Rag1-null mutant rats compared with Dahl SS rats (Fig. 2) . At 12 wk of age (n ϭ 6 -8/group), thymus weight was significantly reduced in the Rag1-null mutants (0.30 Ϯ 0.08 g) compared with the Dahl SS rats (0.56 Ϯ 0.03 g). Individual experiments indicated that the total number of mononuclear cells isolated from the thymus was ϳ30 times lower in the Rag1-null mutant than in the SS. Body weights (395 Ϯ 10 and 400 Ϯ 10 g) and spleen weights (1.36 Ϯ 0.03 and 1.16 Ϯ 0.09 g) were not different between Dahl SS and Rag1-null rats, respectively. Although there was no difference in spleen weight, the total number of splenocytes was ϳ10 times lower in a representative Rag1-null mutant compared with a Dahl SS rats.
Mononuclear cell populations in the blood and tissue. Flow cytometry experiments (n ϭ 5-8/group) demonstrated a significant decrease in the number of circulating CD3ϩ T cells and CD45Rϩ B cells in the Rag1 mutant compared with the SS rats (Fig. 3) . Further flow cytometry of mononuclear cells isolated from the spleen showed a marked decrease in T cells (CD3ϩ) and B cells (CD45Rϩ) in the spleen of the SS-Rag1 em1Mcwi compared with the Dahl SS (Fig. 4) . Immunohistochemical images illustrated the typical rodent spleen anatomy in the SS with a central arteriole immediately surrounded by a region containing T lymphocytes bordered by tissue enriched in B lymphocytes. Consistent with the flow cytometry data, both T and B cells were noticeably decreased in the immunohistochemical images of the Rag1-mutant spleen. Individual experiments indicated that the peripheral blood mononuclear cell concentration and total splenocyte and thymocyte counts were ϳ2-, 10-, and 30-times greater in the SS than in the Rag1-mutant rat. Despite the near total reduction of circulating CD3ϩ cells in the circulation, ϳ43% of the thymocytes were CD4ϩ, CD8ϩ, or CD4ϩ/CD8ϩ in the Rag1 mutant. Finally, we observed approximately equal numbers of CD11bϩ cells (monocytes and macrophages) in the circulation, spleen, and thymus of the Rag1 mutant and Dahl SS.
Blood pressure and albuminuria in Rag1-mutant rats. The changes in arterial blood pressure and albumin excretion rate in SS and SS-Rag1 em1Mcwi fed the high-salt diet are illustrated in Fig. 5 (n ϭ 4 or 5/group) . The 24-h average daily MAP values measured by telemetry were not different between the SS and Rag1-mutant rats during 7 days of low-salt (0.4% NaCl) intake. Blood pressure rapidly and significantly increased in the Dahl SS rats by the second day of the high-NaCl intake. Following a brief plateau in the blood pressure increase between days 4 and 8 of high salt, MAP continued to increase throughout the experiment. The MAP in the Rag1-null rats was also elevated when dietary NaCl intake was increased, although the rate of MAP increase was significantly less than that observed in the SS rats. In the Rag1 mutants, blood pressure was not significantly different from baseline until day 3 of high salt, and the absolute level of MAP was significantly lower than that in the Dahl SS over the entire period of elevated salt intake. The albumin excretion rate was elevated in the SS rats fed low NaCl compared with the Rag1-null mutants (n ϭ 6 -9/group), although the differences did not reach statistical significance. In parallel to the increase in blood pressure, albumin excretion rate was increased on days 7, 14, and 21 of high salt compared with the low-salt value in the SS rats. The albumin excretion rate also increased in the SS-Rag1 em1Mcwi rats when NaCl intake was increased, but the albumin excretion rate in the Rag1 mutant rats was significantly less than observed in the SS rats on each day of high NaCl. As an index of renal function, plasma creatine concentration was significantly different between the Rag1 mutants (0.25 Ϯ 0.03 mg/dl) and the SS (0.34 Ϯ 0.04 mg/dl) after 3 wk of the high-salt diet.
Renal histological changes in Rag1 mutant rats. As indicated in Fig. 6 , the renal histological damage typically observed in SS rats fed a high-salt diet, including blocked and dilated tubules in the outer medulla, was reduced in the Rag1-null rats (n ϭ 4 or 5/group). Histological scoring demonstrated a significant reduction in the glomerular damage index, as well as a reduction in damaged tubules in the outer medulla. Finally, isolation and counting of infiltrating T cells in the kidney showed significantly fewer infiltrating T cells in the kidneys of the Rag1-null mutant rats compared with the Dahl SS kidney after 3 wk of the high-salt diet (Fig. 7, n 
DISCUSSION
The present experiments demonstrate that an intact immune system is necessary for the full expression of salt-sensitive hypertension and renal damage in the Dahl SS rat. Rats with a genetic mutation in the Rag1 gene, which resulted in a depletion of mature T and B cells, demonstrated a significant blunting of salt-sensitive hypertension and renal disease. When dietary NaCl intake was increased, the Dahl SS demonstrated a rapid and progressive increase in blood pressure that was accompanied by a significant increase in albumin excretion rate and marked renal histological damage. Mean arterial pressure and albumin excretion rate also increased in the Rag1-mutant rats when fed the elevated NaCl diet, but the increase was significantly attenuated compared with the SS. The glomerular and tubular damage after 3 wk of high-salt intake was also blunted in the Rag1 mutants, as was the number of infiltrating T cells in the kidney. Despite the large differences in blood pressure and renal damage in the rats fed high NaCl, arterial blood pressure and albumin excretion values were not significantly different from age-matched Dahl SS rats when maintained on a low-NaCl diet.
Previous studies from our laboratory have indicated that immunosuppressive agents attenuate the development of saltsensitive hypertension and renal damage in the Dahl SS rat (3, 4, 5, 17) . Similar findings have been made in many other animal models of hypertension and/or renal disease (7, 21, 22, 23) . Although the large number of studies with similar conclusions indicate an important role of the immune system in cardiovascular disease, potential nonspecific effects of these pharmacological agents cloud the interpretation of these studies. Moreover, the role of immune cells in the time course of disease development is difficult to ascertain with a pharmacological approach. Previous studies from Dr. David Harrison's group have used genetically mutated mouse models to address the role of T lymphocytes in experimental hypertension (11) . Work in the present article describes the development of a rat in which the Rag1 gene has been mutated using ZFN technology in the Dahl SS genetic background, a genetic model of hypertension. These studies utilized a ZFN strategy to mutate the Rag1 gene in the Dahl SS genetic background. This approach, which has been documented for a number of other genes (8, 9, 19) , led to two strains with a mutation in exon 1 of Rag1. The genetic mutation was confirmed by sequencing; and subsequent Western blotting of protein homogenates from the thymus indicated a loss of Rag1-immunoreactive protein in the Rag1-mutant rats. In addition, the mutant rats demonstrated a marked reduction of mature T and B cells in the blood and spleen, with normal body weights, and reduced thymus weights. There were no other developmental abnormalities noted in these animals, although the potential impact of developmental changes and/or alteration in other pathways in the absence of Rag1 protein is a limitation of this gene deletion approach. Qualitatively, the phenotypes observed in the present study are similar to those previously reported in Rag1-/-mice (18) and recently reported in the LEW/Ztm rat with ZFN-mediated disruption of Rag1 (29) .
A number of different types of infiltrating immune cells, including macrophages, T lymphocytes, and B lymphocytes, have been identified in the diseased kidney of hypertensive rats. Since the Rag1 mutants have a reduction in both T and B lymphocytes, it is difficult to ascribe the protective effects to a specific cell type. It is, therefore, possible that the blunted hypertensive response in the Rag1-mutant rats was mediated by a reduction in multiple cell types. Further cell-specific approaches will need to be performed before a definitive conclusion can be made regarding the role of this cell type in Dahl SS hypertension. In support of the concept that T cells are mediating the present effects, recent studies in Rag1-/-mice have indicated that T lymphocytes mediate a significant portion of ANG II-mediated hypertension (11) . The mechanisms leading to the infiltration of these cells into the kidney in Dahl SS hypertension remain to be determined. An additional important question that is not addressed in this study is the relationship between the elevation in blood pressure, the infiltration of T cells, and renal damage; this present experimental approach does not permit us to ascertain the cause-and-effect relationship(s) between these parameters.
The present data demonstrate that genetic mutation of Rag1 in the Dahl SS genetic background results in a decrease in T and B lymphocytes in the blood and spleen. When the mutant rats were challenged with a high-salt diet, the degree of hypertension and renal damage was reduced, indicating that the infiltration of T and/or B cells in the kidney amplifies the Dahl SS disease phenotype. Since renal infiltration of immune cells has also been observed in hypertensive patients (13, 27) , we speculate that these same mechanisms play a role in human hypertension and renal disease.
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